Summit, New Jersey consumer health company, formerly Johnson & Johnson's consumer healthcare division; owns Band-Aid, Listerine, Neutrogena and Tylenol, traded on the NYSE as KVUE, and Kimberly-Clark completed buying it on November 2, 2026.
Market cap $37.1B on 21 Nov 2026
| Third Point Q3 2025 Investor Letter | Third Point returned 3.2% in Q3 2025 on TSMC, Nvidia, CRH, Comfort Systems and PG&E, while Kenvue, DSV, Primo Brands, LSEG and Flutter lost money. | Third Point | Daniel Loeb | Q3 2025 |
| Our bottom-up approach to a top-down crisis | U.S. equity market commentary 2Q 2025 | Bill Nygren describes Oakmark's bottom-up response to the 2025 tariff crisis, as the S&P 500 rose 6% in six months by a volatile path. | Oakmark Funds | Bill Nygren | Q2 2025 |
| Third Point Q1 2026 Investor Letter | Third Point returned -0.6% in Q1 2026; it explains exits from the rails and Kimberly-Clark, its CoStar board campaign, Indra Sistemas and a position in GSE preferreds. | Third Point | Daniel Loeb | Q1 2026 |
Two examples of such exits were our timely sale of a large position in the rails and the complete exit from Kimberly Clark (the successor to last year’s Kenvue position), with the latter benefiting from a spike in demand for defensive securities.Show in the letter ›
Third Point Q1 2026 Investor Letter · Third Point · page 2 · Q1 2026
The top five losers for the quarter, excluding hedges, were Kenvue Inc., DSV A/S, Primo Brands Corp., London Stock Exchange Group PLC, and Flutter Entertainment PLC.Show in the letter ›
Third Point Q3 2025 Investor Letter · Third Point · page 1 · Q3 2025
We also reduced other holdings that were closing in on our sell targets, such as AIG Group, Corteva, CVS and Kenvue.Show in the letter ›
Our bottom-up approach to a top-down crisis | U.S. equity market commentary 2Q 2025 · Oakmark Funds · Q2 2025